- Home
- AUPH vs GEL Comparison
AUPH vs GEL Comparison
Compare AUPH & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | GEL |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AUPH | GEL |
|---|---|---|
| Price | $16.73 | $14.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $17.86 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 737.0K | 231.4K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.67% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.53 | 0.21 |
| Revenue | $283,055,000.00 | ★ $2,912,770,000.00 |
| Revenue This Year | $15.83 | $9.79 |
| Revenue Next Year | $21.30 | N/A |
| P/E Ratio | ★ $31.62 | $66.93 |
| Revenue Growth | 20.38 | ★ 43.60 |
| 52 Week Low | $11.48 | $13.55 |
| 52 Week High | $19.25 | $18.64 |
Technical Indicators
Market Signals| Indicator | AUPH | GEL |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 41.69 |
| Support Level | $15.61 | $13.65 |
| Resistance Level | $17.02 | $14.61 |
| Average True Range (ATR) | 0.40 | 0.30 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 68.77 | 41.11 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.